Trump reaches drug worth offers with 9 extra pharmaceutical corporations
WASHINGTON — 9 drugmakers on Friday unveiled offers with the Trump administration to decrease the costs of a few of their medication, marking the administration’s largest such deal up to now.
The offers are the newest in a collection of agreements with drugmakers which can be geared toward decreasing costs to ranges paid by peer nations. The brand new agreements share many traits with the earlier ones, senior administration officers instructed reporters Friday.
After saying the offers with the drugmakers, President Trump made a shock declaration: He mentioned he plans to satisfy with medical health insurance corporations quickly to attempt to drive their costs down subsequent. The president mentioned he would meet with the businesses subsequent week in Florida or within the first week of the brand new yr within the White Home. His plan to satisfy with insurers comes amid Inexpensive Care Act insurance coverage subsidies expiring, which dangers climbing prices for thousands and thousands of Individuals.
This text is unique to STAT+ subscribers
Unlock this text — plus every day protection and evaluation of the biotech sector — by subscribing to STAT+.
Have already got an account? Log in
To learn the remainder of this story subscribe to STAT+.
